Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

William Pao, former Roche R&D leader and Pfizer CDO, now leads Revelio Therapeutics (formerly Launchpad) as CEO, joins ...

The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...

French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...

Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...

It’s a problem that’s been hovering since the 2017 Dengvaxia controversy led to the suspension of the Department of Health’s (DOH) vaccination campaign against this endemic scourge. On ...

Huacuz caused the checks to be coded as payments to Sanofi Pasteur, Inc., a multinational pharmaceutical company, to conceal ...

A former Taney County Health Department official pleaded guilty to a scheme to embezzle approximately $260,000 from the ...

Residents in a subdivision in Quezon City have launched a campaign against dengue by paying P1 for every dead mosquito presented to the organizers of the drive.

THE findings of the Department of Justice (DOJ) dismissing the 98 Dengvaxia cases 'cannot prevail over the courts,' according ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.